On May 19, 2026, Amgen Inc. held its Annual Meeting where all 12 director nominees were elected, executive compensation was approved by 399 million votes, and Ernst & Young was ratified as accountants with 448 million votes. A proposal for an independent board chairman was rejected with only 73 million votes in favor.